Skip to main content
Clinical Trials/CTRI/2018/03/012834
CTRI/2018/03/012834
Completed
Phase 2

Evaluation of pain on injection, onset and anesthetic efficacy of precooled injection site and 2% lignocaine (4-6�ºC) during maxillary infiltration in patients with symptomatic irreversible pulpitis - a randomized controlled trial

Ishwarya Gurucharan0 sites16 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: null- Symptomatic irreversible pulpitis,Hot tooth
Sponsor
Ishwarya Gurucharan
Enrollment
16
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
February 15, 2019
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Ishwarya Gurucharan

Eligibility Criteria

Inclusion Criteria

  • Healthy adult patients aged 18 to 45 years who are willing to give informed consent
  • Teeth with acute and spontaneous pain
  • Patients with symptomatic irreversible pulpitis in maxillary molars of both the quadrants
  • Presence of vital tissue on access opening

Exclusion Criteria

  • Allergic to Local anesthetics
  • Medically compromised patients (ASA Class III or higher)
  • Patients under medication which may affect the pain assessment
  • Inability to give informed consent
  • presence of Periapical radiolucencies
  • presence of active pathosis in the injection site
  • vertical fractures
  • periodontally compromised teeth
  • nonrestorable teeth

Outcomes

Primary Outcomes

Not specified

Similar Trials